Skip to NavigationSkip to content

News

0
Oxford Immunotec to supply TB diagnostic tests to china to aid in coronavirus crisis
As fears rise over the impact and spread of Chinese coronavirus following news of a rising death toll and the first case occurring in US borders,...
0
NICE declines to recommend Astellas' Xospata in rlapsed/refractory FLT3+ acute myeloid leukaemia
The latest in a series of rejections over the past week, NICE has revealed that it has knocked back the recommendation of Astellas’ Xospata (...
0
Roche's risdiplam hits main goal in infants with spinal muscular atrophy
Roche has announced the success of its survival motor neuron-2 (SMN2) splicing modifier risdiplam in a new trial investigating its efficacy in the...
0
China approves Roche cancer drug Kadcyla
China has approved the import of Roche’s drug for breast cancer, just after it recently won expanded approval in the US, Canada and Europe.
>> More News Stories

Features

Collaborating to realise the potential of precision medicine

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the industry...

>> More Features
>> More News Stories